These phenomena can indicate the DKK-1-mediated promotion of cancer growth by activation of tumor angiogenesis and support the rationale that DKK-1 can be a cancer-specific therapeutic target for HCC treatments. Here, DKK1 is linked to hepatocellular carcinoma.